Drugs / CD123CAR-41BB-CD3zeta-EGFRt-expressing T cells
CD123CAR-41BB-CD3zeta-EGFRt-expressing T cells
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT03114670 | Mar 2017 → Mar 2019 | acute myeloid leukemia | Affiliated Hospital to Academy of Military Medical Sciences | Unknown | No outcome recorded |
Evidence & citations 2 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | CD123CAR-41BB-CD3zeta-EGFRt-expressing T cells | ClinicalTrials.gov intervention name — accepted as the source's own label NCT03114670 ↗ |
| Modality | Cell therapy | “donor-derived chimeric antigen receptor modified-T cell(CART)” NCT03114670 ↗ |